Search - tctmd.com

Displaying 21 - 40 of 302

Sort: Relevancy | Date

Presentation TCT 2016

Issues With Non-inferiority Trials: Choosing the Margin and Comparator; Creep, Noise, and More

Presenter: Roxana Mehran, Pascal Vranckx, Sanjay Kaul

October 30, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: Resolute Cobalt Chromium Durable Polymer-Based Zotarolimus-Eluting Stents

Presenter: Dean J. Kereiakes, Pieter C. Smits, Roxana Mehran

October 30, 2016

Presentation TCT 2016

Debate: What Is the Optimal Study Design for Maximizing Trial Efficiency, Success, and Interpretability? Adaptive Design in A Bayesian Framework!

Presenter: Roxana Mehran, Pascal Vranckx, Scott Berry

October 30, 2016

Presentation TCT 2016

Debate: What Is the Optimal Study Design for Maximizing Trial Efficiency, Success, and Interpretability? Adaptive Design in a Frequentist Framework!

Presenter: Roxana Mehran, Pascal Vranckx, Stuart J. Pocock

October 30, 2016

Presentation TCT 2016

Choice of Primary (or Co-primary) Endpoints: Efficacy, Safety, or Net Clinical Benefit in Superiority and Non-inferiority Trials

Presenter: Roxana Mehran, Pascal Vranckx, Robert A. Harrington

October 30, 2016

News Daily News

Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy

Michael O'Riordan

August 23, 2016

News Daily News

The Hornet’s Nest of Data Sharing: Cardiologist-Led Proposals Do Not Necessarily Agree on Timelines, Reviews

Shelley Wood

August 03, 2016

Presentation SOLACI 2016

The Unmet Needs of DES

Presenter: Roxana Mehran

June 09, 2016

News Conference News EuroPCR 2016

WIN-TAVI Registry Homes in on TAVR Outcomes Unique to Female Patients

Caitlin E. Cox

May 17, 2016

Presentation Fellows 2016

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Presenter: Roxana Mehran

April 15, 2016

Presentation Fellows 2016

Antiplatelet Therapy for the Interventionalist

Presenter: Roxana Mehran

April 15, 2016

Presentation JIM 2016

Intravenous P2Y12 Receptor Inhibitors With Powerful Oral Antiplatelets Are The New Best Option!

Presenter: Roxana Mehran

February 11, 2016

Presentation JIM 2016

Self- Apposing Stents in STEMI:The Stentys Experience

Presenter: Roxana Mehran

February 10, 2016

News Daily News

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

L.A. McKeown

February 09, 2016

News Daily News

Un Documento de AHA Defiende que Hay que Mejorar los Resultados de Mujeres Víctimas de IAM

Caitlin E. Cox

January 25, 2016

News Daily News

AHA 报告为改善女性急性心梗患者结局铺路

Caitlin E. Cox

January 25, 2016

News Daily News

AHA Document Builds the Case for How to Improve Outcomes for Women With Acute MI

Caitlin E. Cox

January 25, 2016

News Daily News

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Yael L. Maxwell

January 05, 2016

News Daily News

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

Yael L. Maxwell

January 05, 2016

News Daily News

HORIZONS-AMI 亚组研究表明，STEMI 患者的症状持续时间可能比 D2B 更重要

Yael L. Maxwell

January 05, 2016

Advertisement

Issues With Non-inferiority Trials: Choosing the Margin and Comparator; Creep, Noise, and More

Stent Design and Comprehensive Data Review: Resolute Cobalt Chromium Durable Polymer-Based Zotarolimus-Eluting Stents

Debate: What Is the Optimal Study Design for Maximizing Trial Efficiency, Success, and Interpretability? Adaptive Design in A Bayesian Framework!

Debate: What Is the Optimal Study Design for Maximizing Trial Efficiency, Success, and Interpretability? Adaptive Design in a Frequentist Framework!

Choice of Primary (or Co-primary) Endpoints: Efficacy, Safety, or Net Clinical Benefit in Superiority and Non-inferiority Trials

Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy

The Hornet’s Nest of Data Sharing: Cardiologist-Led Proposals Do Not Necessarily Agree on Timelines, Reviews

The Unmet Needs of DES

WIN-TAVI Registry Homes in on TAVR Outcomes Unique to Female Patients

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Antiplatelet Therapy for the Interventionalist

Intravenous P2Y12 Receptor Inhibitors With Powerful Oral Antiplatelets Are The New Best Option!

Self- Apposing Stents in STEMI:The Stentys Experience

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

Un Documento de AHA Defiende que Hay que Mejorar los Resultados de Mujeres Víctimas de IAM

AHA 报告为改善女性急性心梗患者结局铺路

AHA Document Builds the Case for How to Improve Outcomes for Women With Acute MI

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

HORIZONS-AMI 亚组研究表明，STEMI 患者的症状持续时间可能比 D2B 更重要

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content